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Objective: Sleep disturbances play a fundamental role in the pathophysiology posttraumatic stress
disorder (PTSD), and are not only a secondary feature. The aim of this study was to validate and
assess the psychometric properties of the Brazilian version of the Pittsburgh Sleep Quality Index
Addendum for PTSD (PSQI-A-BR), a self-report instrument designed to assess the frequency of
seven disruptive nocturnal behaviors, in a sample of participants with and without PTSD.
Methods: PSQI-A was translated into Brazilian Portuguese and applied to a convenience sample of
190 volunteers, with and without PTSD, who had sought treatment for the consequences of a
traumatic event.
Results: The PSQI-A-BR displayed satisfactory internal consistency (Cronbach’s coefficient of 0.83
between all items) and convergent validity with the Clinician Administered PTSD Scale (CAPS), even
when excluding sleep-related items (r = 0.52). Test-retest yielded high agreement in the global PSQI-
A-BR, with good stability over time (r = 0.88). A global PSQI-A-BR cutoff score of 7 yielded a
sensitivity of 79%, specificity of 64%, and a global score of 7 yielded a positive predictive value of 93%
for discriminating participants with PTSD from those without PTSD.
Conclusion: The PSQI-A-BR is a valid instrument for PTSD assessment, applicable to both clinical
and research settings.
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Introduction
Posttraumatic stress disorder (PTSD) is characterized by
the persistence of dysfunctional stress reactions 1 month
or more after exposure to an extreme traumatic event.
The core triad symptom clusters in the DSM-IV-TR
include intrusions, avoidance, and increased arousal.1
In the DSM-5,2 four distinct symptom clusters are
defined, with a distinction between avoidance and
distorted emotions and cognitions. According to the
DSM-IV-TR1 and DSM-5,2 sleep disturbances are part
of the definition of two clusters, namely intrusion
(recurrent distressing dreams of the event) and increased
arousal (difficulties in initiating or maintaining sleep).3
Some evidence suggests that sleep dysfunction plays an
important role in the pathophysiology, clinical and
treatment outcomes of PTSD, and is not only a secondary
feature.4 Thus, it is important to accurately detect and
intervene on sleep in the context of trauma-related
reactions and disorders.4
Generally, patients with PTSD report a broad spectrum
of unspecific sleep-related complaints, such as difficulty
initiating and maintaining sleep, poor sleep quality,
and frequent and lengthy nocturnal awakenings.5
Other disruptive nocturnal behaviors (DNBs) have been
reported, and include trauma-related nightmares, no-
cturnal intrusive memories, distressing dreams not
related to the trauma, sleep terrors, nocturnal panic
attacks, dream enactment behaviors, and other complex
motor behaviors.5,6
The Pittsburgh Sleep Quality Index (PSQI)7 is a
worldwide used instrument developed to assess overall
sleep quality.7,8 However, this instrument does not
measure DNBs frequently observed in PTSD patients.
The PSQI Addendum for PTSD (PSQI-A) was developed
to address this need in trauma-exposed patients.5
Urban violence is currently endemic in Brazil; violent
events are part of daily life.9 Exposure to traumatic events
in Sa˜o Paulo and Rio de Janeiro is highly prevalent:
nearly 90% of people surveyed in these two cities have
faced at least one lifetime traumatic experience. Over
59% of Sa˜o Paulo residents and 63% in Rio de Janeiro
reported a lifetime direct exposure to violence.10 The
1-year prevalence estimates of such events are 9.5%
in Sa˜o Paulo and 11.4% in Rio de Janeiro, with a
high incidence of PTSD among civilians. The 1-year
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prevalence estimates of PTSD are 5% in Sa˜o Paulo and
3.3% in Rio de Janeiro.10 Ribeiro et al. also estimated
lifetime prevalence of PTSD as 10.2% in Sa˜o Paulo and
8.7% in Rio de Janeiro.10
Therefore, the development and validation of reliable
instruments for identification of clinically significant sleep
disturbances related to PTSD and their severity in
Brazilian samples is of paramount importance.9 To date,
there is no validated instrument in Brazilian Portuguese to
evaluate DNBs in trauma-exposed and PTSD patients.
Thus, the validation of the Brazilian version of the PSQI-A
was undertaken. In addition, the fact that the PSQI-A has
also been used in other countries can further enable
cross-cultural research.5,6,11
The aim of this study was to validate and evaluate the
psychometric properties of the Brazilian version of the
PSQI-A (PSQI-A-BR), using criteria of validity, conver-
gent validity, internal consistency and time sensibility.
Methods
The instrument
The PSQI Addendum for PTSD (PSQI-A) is a self-
assessment scale, developed by Germain et al. in 2005,
that consists of seven items to assess seven types of
DNBs reported by PTSD patients.5 The seven items
assess the frequency of hot flashes; general nervous-
ness; memories or nightmares of the traumatic experi-
ence; severe anxiety or panic, not related to traumatic
memories; bad dreams, not related to traumatic mem-
ories; episodes of terror or screaming during sleep
without fully awakening; and episodes of acting out
dreams, such as kicking, punching, running, or scream-
ing. The person is asked to rate the frequency of these
DNBs during the month preceding the completion of the
questionnaire. Each item is rated on a 0-3 scale, with 0 =
not in the past month, 1 = less than once a week, 2 =
once or twice a week, and 3 = three or more times a
week. A global score is obtained from the sum of these
items, ranging from 0-21. In addition, three items are
included for clinical and informative purposes only,
regarding the frequency of anxiety and anger accompa-
nying DNBs and the timing of these events during the
night. These three items are not included in the total
PSQI-A score, nor were they used in the analyses
described herein. The instrument requires less than 5
minutes to complete. The complete PSQI-A-BR is
available elsewhere.5
Translation procedures
Two English-Portuguese expert translators translated the
instrument, resulting in two Portuguese versions, which
were back-translated by two other independent transla-
tors, native speakers of English, unaware of the original
English version. An expert panel and the author of the
original English scale (AG) revised the back-translated
English versions. Minimal semantic issues were found,
e.g., the term ‘‘bed partner’’ was replaced by ‘‘partner,’’ as
the term ‘‘partner’’ implicitly entails ‘‘bed partner’’ in Brazil;
the term ‘‘had episodes of acting out your dreams’’ was
roughly translated to Portuguese as ‘‘had episodes in
which you made gestures and movements while sleep-
ing’’, as, in Brazilian Portuguese, the word ‘‘acting’’ could
be misinterpreted as ‘‘pretending’’ (i.e., acting as in the
work of an actor), with a negative connotation, resulting in
underestimated results of this important item; ‘‘dream’’ in
this sentence was replaced by ‘‘sleep,’’ which is a broader
term. Our working group believes that Brazilians tend to
interpret this sentence literally, not taking into considera-
tion whether the person recalls his or her dreams but still
acts them out. Therefore, this information may be
obtained from the respondent’s bed partner, even if the
respondent does not recall the dream and acts it out.
A final version was developed after an expert panel
worked to reach consensus on discrepancies and
maximize the attainment of semantic, idiomatic, experi-
ential, and conceptual equivalence between the Brazilian
and the original versions.12 To test the understandability
of the instrument,6 a preliminary version was tested on 10
individuals, who were asked to pay close attention to the
meaning and to judge whether there were any issues with
the instrument. In this pretest, the mean age of the
participants was 3464.2 years, 80% were female, and
different educational levels (6 to 30 years of formal
schooling) were represented. All participants were
recruited from the staff of the Universidade Federal de
Sa˜o Paulo (UNIFESP) Violence and Stress Program
(PROVE). None reported any difficulty completing the
instrument, and the final version was identical to the
preliminary one.
Subjects
Individuals seeking treatment for trauma-related disorder
in the UNIFESP PROVE program were screened,
through an interview, for the pertinence of symptom
permanence and need for treatment by a multidisciplinary
team. When individuals were considered eligible for
treatment, were aged 18 years or older, and had suffered
from a traumatic event meeting criterion A of the PTSD
DSM-IV diagnosis, they were invited to take part in the
study.1 All eligible participants based on the preceding
two criteria were informed that participation in this study
was voluntary and would not affect eligibility for treat-
ment. All provided voluntary, written, and informed
consent to participate in the study. The exclusion criteria
were: pregnancy; rotating shift work; unstable major
somatic or mental disorders, as assessed by a trained
psychiatric interviewer;5 or refusal to participate. A
convenience sample of 190 volunteers (73.2% female)
was formed by consecutive patients over a period of 3
years, between 2009 and 2012. Of these, 154 developed
PTSD (PTSD+), and 25 individuals exposed to trauma did
not develop PTSD. The latter group formed the control
group (trauma control group = PTSD-). Information
regarding PTSD was missing for 11 participants. The
mean age for the total sample (n=190) was 40.2611.2
years. Mean age was 39.9611.6 years for the PTSD
group (n=154), and 41.1610.5 for the control group
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(n=25). The two groups did not differ regarding age (t(149)
= 0.5, p = 0.62). Women represented the majority of
participants in both groups (74.7% in the PTSD+ and 64%
in the PTSD- group; chi-square [1] = 1.24, p = 0.33).
Procedures
Participants completed the Brazilian version of the
Pittsburgh Sleep Quality Index (PSQI-BR)8 and the
PSQI-A-BR at intake. The Brazilian version of the
Clinician Administered PTSD Scale (CAPS) was also
administered and used as the gold standard for PTSD
diagnosis and symptom quantification.13 For retest
purposes, 15 days after first assessment, 14 individuals
from the PTSD+ group completed the PSQI-A-BR again
(all individuals were invited to take part in the retest stage,
however, only 14 were available to return to the center
after 15 days). Six months after the intake assessments,
the CAPS, PSQI-A, and PSQI-A-BR were administered
again to all who had completed treatment.
Instruments
The characteristics of the PSQI-A-BR have been
described previously.
The PSQI-BR is a self-assessment instrument devel-
oped to assess sleep quality over an 1-month period and
was validated in Brazilian Portuguese by Bertolasi et al.8
It assesses subjective sleep quality, sleep latency, sleep
duration, habitual sleep efficiency, sleep disturbances,
use of sleeping medication, and daytime dysfunction,
and yields one global score, which ranges from 0 to 21.
A global PSQI score greater than 5 indicates major
difficulties in at least two components or moderate
difficulties in more than three components.7,8 Higher
scores indicate poorer sleep quality.
The CAPS is a 30-item structured diagnostic interview
designed to measure the frequency and intensity of
PTSD symptoms and has been validated in Brazilian
Portuguese by Pupo et al.9 The symptoms are scored on
a 0-4 scale and the total score ranges from 0 to 136.
Scores of 45 or greater are considered indicative of a
positive PTSD screen.9
Statistical analysis
Data were analyzed in SPSS version 20 for Windows,
with the exception of weighted kappa, which was
calculated using MedCalc 12.7.4.0. The Kolmogorov-
Smirnov test was used to test for normality of data. Global
PSQI scores at intake and all PSQI-A-BR items (at both
times) for both groups were significantly non-normal;
global CAPS score, global PSQI-A-BR score, and age
were distributed normally.
Student’s t tests were used to compare total PSQI-A-
BR scores between the PTSD and control groups. The
nonparametric Mann-Whitney U test was used to
compare total PSQI-BR scores and PSQI-A-BR item
scores between the two groups. Cronbach’s coefficient
was used to determine PSQI-A-BR internal consistency
in both study groups.
Pearson’s correlations were used to determine con-
vergent validity between PSQI-A-BR and CAPS scores
from the PTSD group alone and with the control group.
Spearman’s correlations were used to determine con-
vergent validity between non-normal (PSQI-A-BR items,
PSQI-BR) and normal data; three sets of correlations
were conducted: 1) correlations between the PSQI-A-BR
and total scores of the other two instruments (with and
without the control group); 2) correlations between the
PSQI-A-BR and the total scores of the CAPS after
subtracting sleep-related item scores (both groups); and
3) partial correlations controlling for age and for time
elapsed from latest traumatic event (categorized into five
groups): a) less than 1 month, b) between 1 month and 1
day but less than 6 months, c) more than 6 months but
less than 1 year, d) more than 1 year but less than 5
years, and e) more than 5 years, with and without the
control group, even though age did not differ between
groups. This was conducted to evaluate the relationships
between age and time elapsed since the latest traumatic
event and sleep patterns. Sensitivity and specificity were
determined using a receiver operator characteristic
(ROC) analysis of PSQI-A global scores from the two
groups. The positive predictive value was determined
using the cutoff PSQI-A global score that best discrimi-
nated PTSD from trauma control, using the CAPS as the
gold standard.
Sensitivity to time and treatment-related changes were
assessed using data collected from subgroups of PTSD
and control subjects after 6 months in treatment at
PROVE. Both groups received the therapies available at
the institution. Treatments were tailored to patients’
individual needs (psychoeducational, psychotherapeutic,
and/or pharmacological treatment). A paired-sample t test
was used to compare score differences at baseline and 6
months later on the seven items and total PSQI-A-BR
score, as well as total CAPS and PSQI scores.
For test-retest purposes, the intraclass correlation
coefficient (ICC) was used for the global score, as it
is a continuous variable. Quadratic weighted kappa
was calculated for all items of the scale. The Cohen
classification14 was employed to assess percent agree-
ment for test and retest: 1), 0, no agreement; 2) 0.0-0.20,
Table 1 Distribution of time elapsed since last traumatic event
PTSD- (n=25) PTSD+ (n=154)
1 month . 6 months 29.2 28.4
6 months . 1 year 12.5 16.9
1 year . 5 years 20.8 24.3
. 5 years 37.5 30.4
PTSD = posttraumatic stress disorder.
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slight agreement; 3) 0.21-0.40, fair agreement; 4) 0.41-
0.60, moderate agreement; 5) 0.61-0.80, substantial
agreement; 6) 0.81-1.00, almost perfect agreement.
Results
Sleep quality and severity of DNBs between groups
Data were available for 153 individuals with PTSD (one
PSQI-A-BR score in the PTSD group was missing) and
25 individuals without PTSD. For time elapsed since last
traumatic event, see Table 1. Respondents in the PTSD
group reported poorer overall sleep quality (median =
14.0) on the PSQI-BR as compared with PTSD- subjects
(median = 8) (U = 793.00, p , 0.001). The PTSD+ group
also reported significantly higher PSQI-A-BR global
scores than the PTSD- group (PTSD- = 5.564.6;
PTSD+ = 11.465.4; t(176) = -5.1, p , 0.001). Between-
group differences on seven PSQI-A-BR items are
summarized in Table 2.
Psychometric properties of the Brazilian version of the
PSQI-Addendum
Internal consistency
All items of the PSQI-A yielded a Cronbach’s alpha = 0.83,
indicating a unitary underlying construct of DNB. Internal
consistency was not improved by removing any of the
seven PSQI-A-BR items. Furthermore, we found signifi-
cant item-total correlations after controlling for the effect of
age and time elapsed since last traumatic event (Table 3).
The mean PSQI-A-BR item-total correlation was r = 0.7
and all were statistically significant (p , 0.001).
Convergent validity with PTSD scores
We found a significant positive correlation between PSQI-
A-BR and CAPS global scores (r = 0.53, p , 0.001),
between PSQI-A-BR and PSQI-BR scores (rs = 0.67, p ,
0.001), and between all PSQI-A-BR items and total CAPS
and PSQI global scores. These correlations remained
significant after adjusting for age and time elapsed since
last traumatic event (Table 4).
After subtracting the sleep items from the total CAPS
scores, the correlation for total sample remained sig-
nificant (r = 0.52, p , 0.001), indicating that the
relationships between global PSQI-A-BR and PTSD
severity scores were not solely attributable to the weight
of the sleep items on PTSD measures and the PTSD
group did not attenuate the correlations.
Sensitivity, specificity, and positive predictive value
The area under the ROC curve was 0.79. ROC analysis
revealed that a PSQI-A cutoff score o 7 yielded a
sensitivity of 79% and specificity of 64% for the PTSD
group compared to the control group. A PSQI-A-BR score
o 7 yielded a positive predictive value of 93%.
Sensitivity to time and change
Data collected from 53 PTSD patients (mean age 41.1
years, 67% female) and 8 participants from the PTSD-
group (mean age 45.8 years; 62.5% female) were
available for this analysis. For the PTSD- group, there
were no differences between total CAPS scores (-6.66
23.1, p = 0.44) or PSQI-A-BR scores (1.2563.8, p =
0.38) after a 6-month period. However, the PTSD+
group showed a significant reduction in total CAPS
Table 2 Between-group differences in the PSQI Addendum (PSQI-A-BR) for PTSD in the PTSD- and PTSD+ groups
(Mann-Whitney test)
PTSD- (n=25) PTSD+ (n=153)
U pMedian IQR Median IQR
Hot flashes 0 1 2 3 885.5 ,0.001
General nervousness 2 2 3 1 1,355.0 0.011
Memories/nightmares of trauma 1 2 3 2 989.5 ,0.001
Anxiety/panic not related to trauma 0 2 2 2 1,186.0 0.001
Distressing dreams not related to trauma 1 1 1 3 1,422.5 0.034
Episodes of terror 0 1 1 2 1,159.5 0.001
Acting out dreams 0 0 1 2 1,167.5 0.001
IQR = interquartile range; PSQI-BR = Brazilian version of the Pittsburgh Sleep Quality Index; PTSD = posttraumatic stress disorder.
Table 3 PSQI-A-BR item global partial correlations adjusted for age and time elapsed since last traumatic event
Global PSQI-A-BR minus item score*
Hot flashes 0.51
General nervousness 0.62
Memories/nightmares of trauma 0.65
Anxiety/panic not related to trauma 0.65
Distressing dreams not related to trauma 0.66
Episodes of terror 0.54
Acting out dreams 0.45
PSQI-A-BR = Brazilian version of the Pittsburgh Sleep Quality Index Addendum for Posttraumatic Stress Disorder (PTSD).
* All analyses resulted p , 0.001.
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(14.8630.4, p , 0.001) and total PSQI-A-BR scores
after 6 months of treatment (mean = 2.865.3, p ,
0.001). There were no significant differences on the
items distressing dreams not related to trauma,
episodes of terror, or acting out dreams. Test-retest
elicited slight agreement for the items hot flashes and
anxiety/panic not related to trauma, fair agreement for
acting out dreams, moderate agreement for general
nervousness and episodes of terror, and substantial
agreement for memories/nightmares of trauma and
distressing dreams not related to trauma. The global
score yielded almost perfect agreement on the basis of
the ICC (Table 5).
Discussion
The PSQI-A-BR demonstrated satisfactory internal con-
sistency and convergent validity with CAPS, the gold
standard for PTSD evaluation. The Cronbach’s coefficient
of 0.83 indicates high internal consistency among all
PSQI-A-BR items.
In this sample, a cutoff score of 7 yielded acceptable
sensitivity and specificity and a high positive predictive
value for discrimination between victims of violence who
did not develop PTSD and those who did. The previous
study of PSQI-A validation yielded a cutoff valueo 4.5 In
the present study, the cutoff was higher, probably
because the comparison group had also been exposed
to traumatic events in the recent past. Nonetheless, our
findings confirmed data from the validation study of the
original English scale. The far higher cutoff value of this
study may be used in studies conducted in Brazil (and
elsewhere) involving controls recently exposed to trauma;
evidence suggests that a lower cutoff may be used in
studies whose control groups are primarily composed of
individuals not exposed to trauma.5
This study design did not allow us to conduct an
accurate assessment of test-retest reliability, since all
retested patients had received treatment. Nonetheless,
we found stability among all items, although some
(namely hot flashes, anxiety/panic not related to trauma,
and acting out dreams) exhibited low stability, probably
due to treatment effect. However, there was high
agreement in the global PSQI-A-BR score, with good
stability over time. The high internal consistency and
good sensitivity to change in the PTSD group suggest
that the PSQI-A-BR is a reliable instrument. Despite the
small control sample (n=8), the finding that PSQI-A-BR
global scores did not change over a 6-month period in
healthy subjects exposed to a traumatic event also points
to the reliability of the instrument. Finally, the absence of
detailed comorbidity measures limits our ability to spec-
ulate on their potential impact of the psychometric
properties of the instrument.
Nevertheless, this newly validated Brazilian Por-
tuguese instrument can be helpful in the study of
PTSD-related sleep dysfunction, as this disorder is highly
prevalent in Brazil. The instrument showed good psycho-
metric properties, with an excellent positive predictive
value, demonstrating its accuracy for measurement of
DNBs in PTSD, which reinforces its utility for research.
Since DNBs are a core symptom of PTSD and increas-
ingly the object of study, it is essential that a valid
instrument be made available to measure and evaluate
these symptoms and their relationship with other PTSD
symptoms, as well as with PTSD severity.
Table 4 PSQI-A-BR partial correlations with CAPS and PSQI global scores adjusted for age and time elapsed since last
traumatic event
CAPS* PSQI*
Hot flashes 0.408 0.553
General nervousness 0.397 0.552
Memories/nightmares of trauma 0.467 0.539
Anxiety/panic not related to trauma 0.345 0.473
Distressing dreams not related to trauma 0.415 0.498
Episodes of terror 0.448 0.447
Acting out dreams 0.328 0.365
CAPS = Clinician Administered PTSD Scale; PSQI = Pittsburgh Sleep Quality Index; PSQI-A-BR = Brazilian version of the Pittsburgh Sleep
Quality Index Addendum for Posttraumatic Stress Disorder (PTSD).
* All analyses resulted p , 0.001.
Table 5 PSQI-A-BR test-retest reliability
Weighted kappa Quadratic weights
Hot flashes 0.018 Slight
General nervousness 0.452 Moderate
Memories/nightmares of trauma 0.767 Substantial
Anxiety/panic not related to trauma -0.016 Slight
Distressing dreams not related to trauma 0.613 Substantial
Episodes of terror 0.477 Moderate
Acting out dreams 0.302 Fair
Global score* 0.879 Almost perfect
PSQI-A-BR = Brazilian version of the Pittsburgh Sleep Quality Index Addendum for Posttraumatic Stress Disorder (PTSD).
* Intraclass correlation coefficient.
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